No article text was recorded for this version.
glioblastoma prognosis
Version 1 of 121 papers23 conceptsfrozen 2026-10-04
Papers in this version
- Blog: High expression of WDR1 in primary glioblastoma is associated with poor prognosis.
- Blog: Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis
- Blog: Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma
- Blog: Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
- Blog: The overexpression of GPX8 is correlated with poor prognosis in GBM patients
- Blog: The Expression Profiles and Clinical Significance of Mixed Lineage Kinases in Glioma
- Blog: Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma
- Blog: Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma
- Blog: Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy
- Blog: Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy
- Blog: Survival prediction for patients with glioblastoma multiforme using a Cox proportional hazards denoising autoencoder network
- Blog: Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy
- Blog: Accumulation of 99mTc-low-density lipoprotein in human malignant glioma
- Blog: Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
- Blog: Regression and machine learning approaches identify potential risk factors for glioblastoma multiforme
- Blog: Kernel Differential Subgraph Analysis to Reveal the Key Period Affecting Glioblastoma
- Blog: Predicting Clinical Outcomes in Glioblastoma: An Application of Topological and Functional Data Analysis
- Blog: Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis
- Blog: Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients
- Blog: RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
- Blog: Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_glioblastoma_prognosis_1fa03a7f,
title = {glioblastoma prognosis},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/glioblastoma-prognosis/rdr_1fa03a7fd52d463d8180256a3b6d7b38},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_glioblastoma_prognosis_1fa03a7f_v1,
title = {glioblastoma prognosis},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/glioblastoma-prognosis/rdr_1fa03a7fd52d463d8180256a3b6d7b38/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}